We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
10 Year Est. Return
AUM
$4.11B
AUM Growth
+$18.6M
Cap. Flow
-$4.43M
Cap. Flow %
-0.11%
Top 10 Hldgs %
26.54%
Holding
1,091
New
44
Increased
380
Reduced
255
Closed
38

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$14.5M
2
WFC icon
Wells Fargo
WFC
+$12.3M
3
FTNT icon
Fortinet
FTNT
+$12.2M
4
CTSH icon
Cognizant
CTSH
+$11.4M
5
MET icon
MetLife
MET
+$10.2M

Sector Composition

Rank Sector Weight
1 Technology 19.82%
2 Financials 15.29%
3 Consumer Discretionary 12.11%
4 Healthcare 10.51%
5 Communication Services 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
1026
Sarepta Therapeutics
SRPT
$1.57B
$22K ﹤0.01%
286
+88
+44% +$10.4K
STSA
1027
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$22K ﹤0.01%
+1,474
New +$22.9K
MTSI icon
1028
MACOM Technology Solutions
MTSI
$19.2B
$21K ﹤0.01%
+990
New +$19.3K
RETA
1029
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$21K ﹤0.01%
264
BB icon
1030
BlackBerry
BB
$4.98B
$20K ﹤0.01%
3,978
+34
+0.9% +$239
KURA icon
1031
Kura Oncology
KURA
$800M
$20K ﹤0.01%
1,298
AVTR icon
1032
Avantor
AVTR
$9.32B
$19K ﹤0.01%
+1,320
New +$22.4K
VRNT
1033
DELISTED
Verint Systems
VRNT
$19K ﹤0.01%
879
ALTR
1034
DELISTED
Altair Engineering Inc
ALTR
$19K ﹤0.01%
560
MRTX
1035
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$19K ﹤0.01%
242
CDNA icon
1036
CareDx
CDNA
$2.26B
$18K ﹤0.01%
+816
New +$22.6K
DNTH icon
1037
Dianthus Therapeutics
DNTH
$5.84B
$17K ﹤0.01%
105
SAP icon
1038
SAP
SAP
$212B
$16K ﹤0.01%
132
-1,694
-93% -$210K
ICL icon
1039
ICL Group
ICL
$6.53B
$15K ﹤0.01%
3,322
NTNX icon
1040
Nutanix
NTNX
$16B
$15K ﹤0.01%
588
ACGL icon
1041
Arch Capital
ACGL
$34.3B
$14K ﹤0.01%
330
-10,604
-97% -$418K
BOX icon
1042
Box
BOX
$4.37B
$14K ﹤0.01%
836
DNLI icon
1043
Denali Therapeutics
DNLI
$3.65B
$14K ﹤0.01%
918
DOMO icon
1044
Domo
DOMO
$174M
$14K ﹤0.01%
880
SGMO
1045
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$12K ﹤0.01%
1,320
OBSV
1046
DELISTED
ObsEva SA Ordinary Shares
OBSV
$12K ﹤0.01%
1,386
ECOM
1047
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$12K ﹤0.01%
1,298
AKRO
1048
DELISTED
Akero Therapeutics
AKRO
$11K ﹤0.01%
484
SSTI icon
1049
SoundThinking
SSTI
$100M
$11K ﹤0.01%
476
VCIT icon
1050
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$10K ﹤0.01%
112

Similar funds

Elkfork Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Elkfork Partners held 1,091 positions worth $4.11B, up 0.45% from $4.09B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Elkfork Partners's Q3 2019 filing shows 44 new, 380 increased, 255 reduced and 38 closed positions. Its largest new stake was TSMC: 39,844 shares worth $1.85M. The largest sale was Centene, an estimated $14.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Elkfork Partners's largest Q3 2019 buy was TSMC: 39,844 shares worth $1.85M.
  • Elkfork Partners added most to Pluralsight, Inc. Class A Common Stock in Q3 2019, an estimated $14.6M increase.
  • Elkfork Partners's biggest Q3 2019 reduction was Centene, cutting an estimated $14.5M.
  • Elkfork Partners fully exited Service Properties Trust in Q3 2019, selling an estimated $8.05M.
  • Elkfork Partners's ten largest holdings make up 27% of its $4.11B portfolio in Q3 2019.
  • Elkfork Partners opened 44 new positions and closed 38 in Q3 2019.
  • Elkfork Partners's portfolio value rose 0.45% quarter-over-quarter to $4.11B.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.